维生素D对心力衰竭中的心脏功能:对10项随机试验的系统审查和元分析
Xuemeng Chen1, Wenli Zhao2, Yan Zhao1
1Department of Public Health, International College, Krirk University, 10220 Bangkok, Thailand.
Reviews in cardiovascular medicine
|July 30, 2024
概括
补充维生素D似乎对心力衰竭 (HF) 患者没有益处. 这一系统性审查没有发现左心室喷射分数,直径或B型尿素水平的显著改善.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 营养科学 营养科学
背景情况:
- 心力衰竭 (HF) 是一个复杂的临床综合征.
- 在HF患者中,维生素D缺乏是常见的.
- 维生素D补充剂在HF管理中的作用仍然不清楚.
研究的目的:
- 系统评估心力衰竭患者维生素D补充剂的疗效.
- 分析维生素D对关键心脏功能和生物标志物指标的影响.
主要方法:
- 在多个数据库 (PubMed,科学网,Cochrane等) 中进行全面的文献搜索. 在2023年3月之前.
- 包括10项涉及1099名患者的研究.
- 分析左心室喷射分数 (LVEF),左心室末端透缩内径 (LVEDD),B型尿素 (BNP) 和25-氧维生素D (25(OH) D水平.
主要成果:
- 在维生素D补充组和对照组之间,没有观察到LVEF,LVEDD,BNP或25(OH) D水平的统计学上显著差异.
- 在LVEF的平均差异为0.74 (p=0.41),LVEDD为-0.59 (p=0.25),BNP为-0.08 (p=0.34),和25 (OH) D为0.41 (p=0.25).
- 对于LVEF,LVEDD和BNP结果没有发现显著的异质性.
结论:
- 维生素D补充剂在心力衰竭患者的治疗中没有显示出临床益处.
- 目前的证据表明,维生素D补充不是改善HF心脏结果的推治疗策略.
- 可能需要进一步的研究来探索潜在的特定亚群或维生素D在心血管健康中的替代作用.
更多相关视频
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
8.5K
07:24Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
Published on: April 8, 2013
24.2K
相关概念视频
01:22Heart Failure Drugs: Diuretics
355
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
355
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:26Heart Failure Drugs: Inotropic Agents
555
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
555
01:22Heart Failure Drugs: β-Blockers
332
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
332
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
413
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413
01:29Pathophysiology of Cardiac Performance
624
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
624